From Interferon to Checkpoint Inhibition Therapy-A Systematic Review of New Immune-Modulating Agents in Bacillus Calmette-Guérin (BCG) Refractory Non-Muscle-Invasive Bladder Cancer (NMIBC).

Susanne Deininger; Peter Törzsök; Michael Mitterberger; Maximilian Pallauf; David Oswald; Christian Deininger; Lukas Lusuardi

doi:10.3390/cancers14030694

From Interferon to Checkpoint Inhibition Therapy-A Systematic Review of New Immune-Modulating Agents in Bacillus Calmette-Guérin (BCG) Refractory Non-Muscle-Invasive Bladder Cancer (NMIBC).

Susanne Deininger^* (Erstautor/-in), Peter Törzsök (Co-Autor/-in), Michael Mitterberger (Co-Autor/-in), Maximilian Pallauf (Co-Autor/-in), David Oswald (Co-Autor/-in), Christian Deininger (Co-Autor/-in), Lukas Lusuardi (Letztautor/-in)

^*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift › Übersichtsarbeit › Begutachtung

7 Quellenangaben (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	Cancers
Jahrgang	14
Ausgabenummer	3
DOIs	https://doi.org/10.3390/cancers14030694
Publikationsstatus	Veröffentlicht - 2022

Zugriff auf Dokument

10.3390/cancers14030694

Dieses zitieren

@article{934912cac19d46dbbdd5c6ce05c6eb61,

title = "From Interferon to Checkpoint Inhibition Therapy-A Systematic Review of New Immune-Modulating Agents in Bacillus Calmette-Gu{\'e}rin (BCG) Refractory Non-Muscle-Invasive Bladder Cancer (NMIBC).",

keywords = "TUMOR-INFILTRATING LYMPHOCYTES, CARCINOMA IN-SITU, METASTATIC UROTHELIAL CARCINOMA, PHASE-II, SINGLE-ARM, HIGH-GRADE, OPEN-LABEL, RADICAL CYSTECTOMY, VACCINE, RISK",

author = "Susanne Deininger and Peter T{\"o}rzs{\"o}k and Michael Mitterberger and Maximilian Pallauf and David Oswald and Christian Deininger and Lukas Lusuardi",

note = "Deininger C: Department of Orthopedics and Traumatology, Salzburg University Hospital, Paracelsus Medical University, 5020 Salzburg, Austria; Spinal Cord Injury and Tissue Regeneration Center Salzburg, Institute of Tendon and Bone Regeneration, Paracelsus Medical University, 5020 Salzburg, Austria; Deininger S, T{\"o}rzs{\"o}k, Mitterberger, Pallauf, Oswald, Lusuardi : 1 Department of Urology and Andrology, Salzburg University Hospital, Paracelsus Medical University, 5020 Salzburg, Austria. ",

year = "2022",

doi = "10.3390/cancers14030694",

language = "English",

volume = "14",

journal = "Cancers",

issn = "2072-6694",

publisher = "MDPI",

number = "3",

}

From Interferon to Checkpoint Inhibition Therapy-A Systematic Review of New Immune-Modulating Agents in Bacillus Calmette-Guérin (BCG) Refractory Non-Muscle-Invasive Bladder Cancer (NMIBC). / Deininger, Susanne (Erstautor/-in); Törzsök, Peter (Co-Autor/-in); Mitterberger, Michael (Co-Autor/-in) et al.
in: Cancers, Jahrgang 14, Nr. 3, 2022.

Publikation: Beitrag in Fachzeitschrift › Übersichtsarbeit › Begutachtung

TY - JOUR

T1 - From Interferon to Checkpoint Inhibition Therapy-A Systematic Review of New Immune-Modulating Agents in Bacillus Calmette-Guérin (BCG) Refractory Non-Muscle-Invasive Bladder Cancer (NMIBC).

AU - Deininger, Susanne

AU - Törzsök, Peter

AU - Mitterberger, Michael

AU - Pallauf, Maximilian

AU - Oswald, David

AU - Deininger, Christian

AU - Lusuardi, Lukas

N1 - Deininger C: Department of Orthopedics and Traumatology, Salzburg University Hospital, Paracelsus Medical University, 5020 Salzburg, Austria; Spinal Cord Injury and Tissue Regeneration Center Salzburg, Institute of Tendon and Bone Regeneration, Paracelsus Medical University, 5020 Salzburg, Austria; Deininger S, Törzsök, Mitterberger, Pallauf, Oswald, Lusuardi : 1 Department of Urology and Andrology, Salzburg University Hospital, Paracelsus Medical University, 5020 Salzburg, Austria.

PY - 2022

Y1 - 2022

KW - TUMOR-INFILTRATING LYMPHOCYTES

KW - CARCINOMA IN-SITU

KW - METASTATIC UROTHELIAL CARCINOMA

KW - PHASE-II

KW - SINGLE-ARM

KW - HIGH-GRADE

KW - OPEN-LABEL

KW - RADICAL CYSTECTOMY

KW - VACCINE

KW - RISK

U2 - 10.3390/cancers14030694

DO - 10.3390/cancers14030694

M3 - Review article

C2 - 35158964

SN - 2072-6694

VL - 14

JO - Cancers

JF - Cancers

IS - 3

ER -